Last10K.com

Aeterna Zentaris Inc. (AEZS) SEC Filing 6-K Foreign Issuer Report for the period ending Friday, September 30, 2022

Aeterna Zentaris Inc.

HISTORY TOOLS
CIK: 1113423 Ticker: AEZS

View differences made from one to another to evaluate Aeterna Zentaris Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aeterna Zentaris Inc..

Continue

Assess how Aeterna Zentaris Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aeterna Zentaris Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 6-K Foreign Issuer Report

Cover
Condensed Interim Consolidated Statements Of Cash Flows (Unaudited)
Condensed Interim Consolidated Statements Of Changes In Shareholders' Equity (Unaudited)
Condensed Interim Consolidated Statements Of Comprehensive Loss (Unaudited)
Condensed Interim Consolidated Statements Of Financial Position (Unaudited)
Business Overview
Business Overview (Tables)
Commitments
Commitments (Details Narrative)
Commitments (Tables)
Critical Accounting Estimates And Judgements
Employee Future Benefits
Employee Future Benefits (Details Narrative)
Employee Future Benefits (Tables)
License And Supply Arrangements
License And Supply Arrangements (Details Narrative)
License And Supply Arrangements (Tables)
Net Loss Per Share
Net Loss Per Share (Tables)
Payables And Accrued Liabilities
Payables And Accrued Liabilities (Tables)
Prepaid Expenses And Other Current Assets
Prepaid Expenses And Other Current Assets (Tables)
Segment Information
Share Capital, Warrants And Other Capital
Share Capital, Warrants And Other Capital (Details Narrative)
Share Capital, Warrants And Other Capital (Tables)
Summary Of Assumptions To Determine Share-Based Compensation Costs (Details)
Summary Of Changes In Operating Assets And Liabilities Explanatory (Details)
Summary Of Detailed Information About Payables And Accrued Liabilities Explanatory (Details)
Summary Of Detailed Information About Restatement Explanatory (Details)
Summary Of Detailed Trade And Other Receivables Explanatory (Details)
Summary Of Detailed Trade And Other Receivables Explanatory (Details) (Parenthetical)
Summary Of Earnings Per Share Explanatory (Details)
Summary Of Fair Value Of Warrants Assumptions Explanatory (Details)
Summary Of Finance Lease And Operating Lease By Lessee Explanatory (Details)
Summary Of Net Defined Benefit Liability Asset Explanatory (Details)
Summary Of Number And Weighted Average Exercise Prices Of Share Options Explanatory (Details)
Summary Of Prepaid Expenses And Other Current Assets Explanatory (Details)
Summary Of Research And Development And Revenue Related Milestone Payments Explanatory (Details)
Summary Of Revenue Explanatory (Details)
Summary Of Warrants Exercise Transactions Explanatory (Details)
Supplemental Disclosure Of Cash Flow Information
Supplemental Disclosure Of Cash Flow Information (Tables)
Trade And Other Receivables
Trade And Other Receivables (Tables)

Material Contracts, Statements, Certifications & more

Aeterna Zentaris Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Exhibit 99.2: Additional Exhibits
Exhibit 99.3: Additional Exhibits
Exhibit 99.4: Additional Exhibits
Ticker: AEZS
CIK: 1113423
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001493152-22-030294
Submitted to the SEC: Thu Nov 03 2022 8:05:47 AM EST
Accepted by the SEC: Thu Nov 03 2022
Period: Friday, September 30, 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/aezs/0001493152-22-030294.htm